IT Tech Packaging

ITP

Capitalización de mercado USD 2.32 M

Company granted plan period through April 15, 2027 to complete delayed SEC periodic filings BAODING, China, Oct. 9, 2026 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE American: ITP) ("ITP" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced that it is not in compliance with the continued listing standards of NYSE American LLC ("NYSE American" or the "Exchange") and that its listing is being continued pursuant to an extension granted by NYSE Regulation. The targeted completion date of the plan period (the "New Cure Deadline") is April 15, 2027.

Sanofi's Wayrilz approved in Japan to treat immune thrombocytopenia Wayrilz is a BTK inhibitor that works through multi-immune modulation to help address the underlying causes of immune thrombocytopenia (ITP) Approval based on the LUNA 3 phase 3 study that demonstrated rapid and durable platelet response and improvements in other symptoms ITP is a rare disease of complex immune dysregulation leading to lower platelet counts, bleeding, and reduced quality of life Paris, June 23, 2026. The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization to Wayrilz (rilzabrutinib), a novel oral reversible Bruton's tyrosine kinase inhibitor (BTKi), for the treatment of persistent or chronic immune thrombocytopenia (ITP) in patients who do not respond sufficiently to other treatments or in whom tolerability is considered to be problematic.

Data demonstrate favorable safety and tolerability profile, robust B-cell depletion, and encouraging platelet responses in heavily pretreated patients with primary immune thrombocytopenia Enrollment ongoing in the high dose cohort, with additional data anticipated by year-end 2026 WELLESLEY HILLS, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced initial data from the ongoing Phase 1b portion of its Phase 1b/2a study evaluating budoprutug, an anti-CD19 monoclonal antibody, in adults with primary immune thrombocytopenia (ITP) demonstrating an encouraging safety and tolerability profile, robust B-cell depletion, and meaningful platelet responses in heavily pretreated patients.

BAODING, China, April 20, 2026 /PRNewswire/ -- IT Tech Packaging Inc. (NYSE American: ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, received an official notice of noncompliance (the "NYSE American Notice") from NYSE Regulation ("NYSE") stating that the Company is not in compliance with NYSE American continued listing standards (the "Filing Delinquency Notification") due to the failure to timely file the Company's Form 10-K for the year ended December 31, 2025 (the "Delinquent Report") by the filing due date of April 15, 2026 (the "Filing Delinquency"). The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide (the "Company Guide").

BAODING, China , Oct. 31, 2025 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE American: ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced the results of the Company's 2025 Annual General Meeting of Stockholders (the "Annual Meeting") held at the Company's production base in Wei County, Hebei Province, China. at 10:00 a.m.

BAODING, China , Sept. 11, 2025 /PRNewswire/ -- IT Tech Packaging, Inc. ("IT Tech Packaging", the "Company") (NYSE American: ITP) announced today that the Company had become aware of unusual trading activity in its common stock on the NYSE American LLC (the "NYSE American") on September 8 and September 9, 2025.

BAODING, China , Sept. 8, 2025 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE American: ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced that it has filed a definitive proxy statement for its 2025 annual general meeting of stockholders and expects to hold its 2025 annual general meeting of stockholders on October 31, 2025 (local time) at its production base in Wei County, Hebei Province, China.

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

BAODING, China , May 13, 2025 /PRNewswire/ -- IT Tech Packaging Inc. (NYSE American: ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced the pricing of a public offering of 6,899,500 shares of its common stock at a price to the public of $0.20 per share. The gross proceeds from the offering to IT Tech Packaging are expected to be approximately $1.4 million, before deducting offering fees and expenses.

As of Dec. 31, 2024, three stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.